More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...

People with Parkinson's disease and Lewy body dementia have increased rates of incident depression from seven to eight years ...

Johnson & Johnson’s (J&J) Caplyta (lumateperone) plus antidepressants nearly doubled the likelihood of remission after six ...

Depression that appears later in life is often viewed as a response to declining health, but emerging evidence suggests it may sometimes signal deeper neurological changes.

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...

Recent medical research indicates that the heightened risk of heart disease observed in patients with depression or anxiety ...

Adding cognitive behavioral therapy to quetiapine in mood disorders is linked to reduced suicide risk and depressive symptoms ...

Findings reveal that vagus nerve stimulation leads to lasting benefits in treatment-resistant depression, improving function ...

The findings one day could allow people with multiple mental health conditions to be treated with a single therapy, ...

CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled data ...